本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Travere Therapeutics, Inc.

21.15
+0.39001.88%
盘后21.150.00000.00%16:20 EDT
成交量:233.38万
成交额:4,890.40万
市值:18.78亿
市盈率:-5.19
高:21.71
开:21.09
低:20.15
收:20.76
数据加载中...
2023/02/23

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/02/17

重要事件披露

8-K - Current report
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/09

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/09

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/01/09

重要事件披露

8-K - Current report
2022/10/28

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/10/27

重要事件披露

8-K - Current report
2022/10/27

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/10/13

重要事件披露

8-K - Current report
2022/08/22

重要事件披露

8-K - Current report
2022/08/18

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/08/17

重要事件披露

8-K/A [Amend] - Current report
2022/08/04

重要事件披露

8-K - Current report
2022/08/04

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/05/16

重要事件披露

8-K - Current report
2022/05/16

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals